TRDA Insider Trading

Insider Ownership Percentage: 7.59%
Insider Buying (Last 12 Months): $151,226.80
Insider Selling (Last 12 Months): $1,487,430.79

Entrada Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at Entrada Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Entrada Therapeutics Share Price & Price History

Current Price: $17.59
Price Change: Price Increase of +0.31 (1.79%)
As of 12/20/2024 06:16 PM ET

This chart shows the closing price history over time for TRDA up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Entrada Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/10/2024Bioventures 2018 L.P. MpmMajor ShareholderSell22,935$20.77$476,359.954,402,849View SEC Filing Icon  
12/2/2024Kory James WentworthCFOSell5,000$20.00$100,000.0073,849View SEC Filing Icon  
11/29/2024Kory James WentworthCFOSell1,000$19.97$19,970.0073,849View SEC Filing Icon  
11/13/2024Natarajan SethuramanInsiderSell2,700$20.04$54,108.00160,888View SEC Filing Icon  
11/11/2024Kory James WentworthCFOSell8,637$19.98$172,567.2673,849View SEC Filing Icon  
11/11/2024Natarajan SethuramanInsiderSell1,409$20.01$28,194.09163,588View SEC Filing Icon  
10/16/2024Natarajan SethuramanInsiderSell600$18.00$10,800.00183,216View SEC Filing Icon  
9/26/2024Nathan J DowdenCOOSell847$16.00$13,552.00125,149View SEC Filing Icon  
9/9/2024Kory James WentworthCFOSell3,195$14.97$47,829.1576,486View SEC Filing Icon  
9/9/2024Natarajan SethuramanInsiderSell2,642$15.09$39,867.78183,816View SEC Filing Icon  
9/9/2024Nathan J DowdenCOOSell1,904$15.07$28,693.28125,996View SEC Filing Icon  
9/6/2024Natarajan SethuramanInsiderSell600$15.24$9,144.00186,458View SEC Filing Icon  
9/6/2024Nathan J DowdenCOOSell399$15.19$6,060.81127,900View SEC Filing Icon  
7/15/2024Dipal DoshiCEOSell1,600$17.81$28,496.00334,475View SEC Filing Icon  
7/15/2024Natarajan SethuramanInsiderSell638$18.00$11,484.00188,814View SEC Filing Icon  
7/12/2024Dipal DoshiCEOSell300$18.00$5,400.00336,075View SEC Filing Icon  
7/12/2024Natarajan SethuramanInsiderSell600$18.00$10,800.00189,452View SEC Filing Icon  
7/8/2024Kory James WentworthCFOSell1,758$14.95$26,282.1081,412View SEC Filing Icon  
6/13/2024Dipal DoshiCEOSell1,000$16.17$16,170.00336,375View SEC Filing Icon  
5/20/2024Natarajan SethuramanInsiderSell9,675$15.19$146,963.25190,052View SEC Filing Icon  
5/16/2024Dipal DoshiCEOSell1,800$15.00$27,000.00338,575View SEC Filing Icon  
5/16/2024Natarajan SethuramanInsiderSell1,000$15.00$15,000.00208,032View SEC Filing Icon  
5/8/2024Peter S KimDirectorBuy2,276$14.04$31,955.0465,212View SEC Filing Icon  
4/8/2024Peter S KimDirectorBuy2,600$13.57$35,282.0062,936View SEC Filing Icon  
3/28/2024Peter S KimDirectorBuy1,512$13.75$20,790.0060,336View SEC Filing Icon  
3/25/2024Peter S KimDirectorBuy3,180$13.36$42,484.8056,074View SEC Filing Icon  
3/21/2024Peter S KimDirectorBuy704$13.24$9,320.9649,776View SEC Filing Icon  
3/19/2024Peter S KimDirectorBuy900$12.66$11,394.0047,944View SEC Filing Icon  
2/15/2024Dipal DoshiCEOSell1,000$15.00$15,000.00243,279View SEC Filing Icon  
1/16/2024Dipal DoshiCEOSell1,000$15.99$15,990.00244,279View SEC Filing Icon  
12/26/2023Kory James WentworthCFOSell94$16.67$1,566.9849,571View SEC Filing Icon  
12/22/2023Kory James WentworthCFOSell10,206$15.69$160,132.1449,571View SEC Filing Icon  
12/20/2023Dipal DoshiCEOSell1,000$15.00$15,000.00245,279View SEC Filing Icon  
11/13/2023Dipal DoshiCEOSell1,000$16.23$16,230.00246,279View SEC Filing Icon  
10/17/2023Dipal DoshiCEOSell1,000$15.00$15,000.00247,279View SEC Filing Icon  
9/13/2023Dipal DoshiCEOSell1,000$15.00$15,000.00248,279View SEC Filing Icon  
9/6/2023Kory James WentworthCFOSell950$13.48$12,806.0049,571View SEC Filing Icon  
9/6/2023Nathan J DowdenCOOSell972$13.47$13,092.8448,168View SEC Filing Icon  
9/6/2023Nerissa KreherInsiderSell892$13.48$12,024.1640,037View SEC Filing Icon  
8/14/2023Dipal DoshiCEOSell1,000$15.67$15,670.00201,069View SEC Filing Icon  
8/4/2023Nerissa KreherInsiderSell6,898$14.14$97,537.7227,130View SEC Filing Icon  
8/2/2023Nerissa KreherInsiderSell10,348$15.19$157,186.1227,130View SEC Filing Icon  
7/11/2023Kory James WentworthCFOSell3,884$18.00$69,912.0036,747View SEC Filing Icon  
7/10/2023Natarajan SethuramanInsiderSell3,026$18.00$54,468.00168,299View SEC Filing Icon  
7/10/2023Nathan J DowdenCOOSell3,200$18.00$57,600.0039,273View SEC Filing Icon  
6/22/2023Nathan J DowdenCOOSell7,097$16.02$113,693.9442,473View SEC Filing Icon  
6/21/2023Kory James WentworthCFOSell17,500$15.01$262,675.0027,957View SEC Filing Icon  
6/20/2023Nathan J DowdenCOOSell8,885$14.94$132,741.9049,570View SEC Filing Icon  
4/27/2023Dipal DoshiCEOSell2,000$13.71$27,420.00202,069View SEC Filing Icon  
4/17/2023Dipal DoshiCEOSell2,092$18.01$37,676.92204,069View SEC Filing Icon  
4/17/2023Natarajan SethuramanInsiderSell3,961$18.00$71,298.00171,325View SEC Filing Icon  
3/27/2023Dipal DoshiCEOSell2,000$14.72$29,440.00255,811View SEC Filing Icon  
1/27/2023Dipal DoshiCEOSell2,000$12.00$24,000.00163,835View SEC Filing Icon  
1/9/2023Dipal DoshiCEOSell2,410$15.02$36,198.20165,835View SEC Filing Icon  
12/29/2022Dipal DoshiCEOSell400$15.01$6,004.00168,245View SEC Filing Icon  
12/27/2022Dipal DoshiCEOSell9,669$15.02$145,228.38173,166View SEC Filing Icon  
12/8/2022Kory James WentworthCFOSell4,550$18.95$86,222.5016,509View SEC Filing Icon  
12/5/2022Kory James WentworthCFOSell200$18.05$3,610.0016,509View SEC Filing Icon  
12/2/2022Kory James WentworthCFOSell2,910$18.20$52,962.0016,509View SEC Filing Icon  
11/28/2022Dipal DoshiCEOSell2,000$13.91$27,820.00182,835View SEC Filing Icon  
10/31/2022Nathan J DowdenCOOSell2,100$24.05$50,505.0045,283View SEC Filing Icon  
10/27/2022Dipal DoshiCEOSell2,000$21.66$43,320.00184,835View SEC Filing Icon  
10/25/2022Nerissa KreherInsiderSell8,040$20.88$167,875.2020,716View SEC Filing Icon  
10/24/2022Dipal DoshiCEOSell2,342$19.30$45,200.60198,896View SEC Filing Icon  
10/24/2022Nathan J DowdenCOOSell2,404$19.30$46,397.2056,731View SEC Filing Icon  
10/20/2022Dipal DoshiCEOSell811$18.01$14,606.11204,024View SEC Filing Icon  
10/20/2022Nathan J DowdenCOOSell905$18.07$16,353.3561,906View SEC Filing Icon  
9/28/2022Dipal DoshiCEOSell3,085$15.23$46,984.55204,835View SEC Filing Icon  
9/28/2022Nerissa KreherInsiderSell3,122$15.25$47,610.5020,716View SEC Filing Icon  
9/26/2022Dipal DoshiCEOSell3,083$15.32$47,231.56212,339View SEC Filing Icon  
9/26/2022Nathan J DowdenCOOSell1,544$15.45$23,854.8062,811View SEC Filing Icon  
9/26/2022Nerissa KreherInsiderSell3,068$15.33$47,032.4420,716View SEC Filing Icon  
9/23/2022Dipal DoshiCEOSell1,023$15.07$15,416.61215,422View SEC Filing Icon  
9/23/2022Nathan J DowdenCOOSell1,018$15.07$15,341.2664,355View SEC Filing Icon  
9/23/2022Nerissa KreherInsiderSell939$15.09$14,169.5120,716View SEC Filing Icon  
9/21/2022Dipal DoshiCEOSell3,402$15.12$51,438.24216,445View SEC Filing Icon  
9/21/2022Nathan J DowdenCOOSell3,275$15.13$49,550.7565,373View SEC Filing Icon  
9/21/2022Nerissa KreherInsiderSell3,341$15.08$50,382.2820,716View SEC Filing Icon  
9/15/2022Dipal DoshiCEOSell200$15.04$3,008.00219,847View SEC Filing Icon  
9/15/2022Nathan J DowdenCOOSell100$15.01$1,501.0068,648View SEC Filing Icon  
9/15/2022Nerissa KreherInsiderSell106$15.01$1,591.0620,716View SEC Filing Icon  
9/9/2022Nerissa KreherInsiderSell800$15.07$12,056.0020,716View SEC Filing Icon  
9/8/2022Dipal DoshiCEOSell1,100$15.16$16,676.00220,735View SEC Filing Icon  
9/8/2022Nathan J DowdenCOOSell912$15.15$13,816.8069,613View SEC Filing Icon  
8/31/2022Dipal DoshiCEOSell171$12.00$2,052.00206,710View SEC Filing Icon  
8/29/2022Dipal DoshiCEOSell1,639$12.88$21,110.32207,071View SEC Filing Icon  
8/25/2022Kory James WentworthCFOSell1,551$14.18$21,993.1810,986View SEC Filing Icon  
8/23/2022Kory James WentworthCFOSell2,909$13.09$38,078.8114,538View SEC Filing Icon  
8/18/2022Kory James WentworthCFOSell200$13.00$2,600.0020,221View SEC Filing Icon  
8/16/2022Kory James WentworthCFOSell200$13.00$2,600.0020,441View SEC Filing Icon  
7/27/2022Dipal DoshiCEOSell2,000$12.00$24,000.00208,710View SEC Filing Icon  
6/27/2022Dipal DoshiCEOSell4,000$12.00$48,000.00210,710View SEC Filing Icon  
6/27/2022Nathan J DowdenCOOSell7,714$13.00$100,282.0064,893View SEC Filing Icon  
6/6/2022Bros. Advisors Lp BakerMajor ShareholderBuy38,304$6.41$245,528.644,501,658View SEC Filing Icon  
6/2/2022Bros. Advisors Lp BakerMajor ShareholderBuy2,643$5.82$15,382.264,467,393View SEC Filing Icon  
5/23/2022Bros. Advisors Lp BakerMajor ShareholderBuy7,837$5.99$46,943.634,443,719View SEC Filing Icon  
5/20/2022Bros. Advisors Lp BakerMajor ShareholderBuy16,849$5.84$98,398.164,436,709View SEC Filing Icon  
5/18/2022Bros. Advisors Lp BakerMajor ShareholderBuy34,433$6.00$206,598.004,421,689View SEC Filing Icon  
5/16/2022Bros. Advisors Lp BakerMajor ShareholderBuy19,000$5.83$110,770.004,374,493View SEC Filing Icon  
1/12/2022John F. CrowleyDirectorBuy5,000$9.71$48,550.00View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Entrada Therapeutics (NASDAQ:TRDA)

86.39% of Entrada Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at TRDA by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Entrada Therapeutics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/19/2024Barclays PLC45,110$0.72M0.0%+210.6%0.121%Search for SEC Filing on Google Icon
11/16/2024Geode Capital Management LLC576,451$9.21M0.0%+8.8%1.540%Search for SEC Filing on Google Icon
11/15/2024Barclays PLC45,110$0.72M0.0%+210.6%0.121%Search for SEC Filing on Google Icon
11/15/2024Public Employees Retirement System of Ohio16,259$0.26M0.0%+89.1%0.043%Search for SEC Filing on Google Icon
11/15/2024XTX Topco Ltd39,670$0.63M0.0%N/A0.106%Search for SEC Filing on Google Icon
11/15/2024Jane Street Group LLC15,514$0.25M0.0%-42.0%0.041%Search for SEC Filing on Google Icon
11/15/2024Wellington Management Group LLP1,029,369$16.45M0.0%-0.4%2.751%Search for SEC Filing on Google Icon
11/15/2024State Street Corp469,601$7.50M0.0%+5.5%1.255%Search for SEC Filing on Google Icon
11/15/2024Jacobs Levy Equity Management Inc.201,803$3.23M0.0%+50.3%0.539%Search for SEC Filing on Google Icon
11/15/2024Janus Henderson Group PLC1,711,459$27.36M0.0%+10.5%4.574%Search for SEC Filing on Google Icon
11/14/2024Martingale Asset Management L P37,923$0.61M0.0%+36.9%0.101%Search for SEC Filing on Google Icon
11/14/2024UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC14,156$0.23M0.0%+34.7%0.038%Search for SEC Filing on Google Icon
11/13/2024FMR LLC1,743,498$27.86M0.0%-4.7%4.659%Search for SEC Filing on Google Icon
11/12/2024Charles Schwab Investment Management Inc.185,984$2.97M0.0%+14.6%0.497%Search for SEC Filing on Google Icon
11/12/2024Massachusetts Financial Services Co. MA69,394$1.11M0.0%N/A0.185%Search for SEC Filing on Google Icon
11/8/2024Connor Clark & Lunn Investment Management Ltd.138,605$2.22M0.0%+132.4%0.370%Search for SEC Filing on Google Icon
11/5/2024GSA Capital Partners LLP36,577$0.59M0.0%+71.8%0.098%Search for SEC Filing on Google Icon
11/4/2024Los Angeles Capital Management LLC33,932$0.54M0.0%N/A0.091%Search for SEC Filing on Google Icon
10/28/2024US Bancorp DE2,658$42K0.0%N/A0.007%Search for SEC Filing on Google Icon
10/23/2024BayBridge Capital Group LLC29,039$0.46M0.3%N/A0.086%Search for SEC Filing on Google Icon
10/19/2024Allspring Global Investments Holdings LLC20,521$0.33M0.0%-25.7%0.055%Search for SEC Filing on Google Icon
10/3/2024SG Americas Securities LLC9,745$0.16M0.0%N/A0.026%Search for SEC Filing on Google Icon
8/15/2024The Manufacturers Life Insurance Company57,098$0.81M0.0%+3.9%0.169%Search for SEC Filing on Google Icon
8/14/2024Squarepoint Ops LLC25,950$0.37M0.0%-23.9%0.077%Search for SEC Filing on Google Icon
8/14/2024Marshall Wace LLP65,943$0.94M0.0%+27.5%0.195%Search for SEC Filing on Google Icon
8/9/2024Renaissance Technologies LLC44,600$0.64M0.0%N/A0.132%Search for SEC Filing on Google Icon
8/8/2024American Century Companies Inc.384,973$5.49M0.0%+5.1%1.140%Search for SEC Filing on Google Icon
8/6/2024Acadian Asset Management LLC13,367$0.19M0.0%+135.1%0.040%Search for SEC Filing on Google Icon
8/1/2024Rhumbline Advisers36,940$0.53M0.0%+25.3%0.109%Search for SEC Filing on Google Icon
7/26/2024Allspring Global Investments Holdings LLC27,631$0.39M0.0%+87.2%0.082%Search for SEC Filing on Google Icon
7/26/2024Bank of New York Mellon Corp125,436$1.79M0.0%+13.4%0.372%Search for SEC Filing on Google Icon
5/16/2024California State Teachers Retirement System12,631$0.18M0.0%-11.1%0.037%Search for SEC Filing on Google Icon
5/15/2024Price T Rowe Associates Inc. MD2,753,357$39.02M0.0%-8.5%8.156%Search for SEC Filing on Google Icon
5/10/2024Acadian Asset Management LLC5,685$79K0.0%N/A0.017%Search for SEC Filing on Google Icon
5/10/2024Vanguard Group Inc.1,078,908$15.29M0.0%+1.3%3.203%Search for SEC Filing on Google Icon
5/7/2024SG Americas Securities LLC7,687$0.11M0.0%-34.4%0.023%Search for SEC Filing on Google Icon
4/30/2024Allspring Global Investments Holdings LLC14,763$0.21M0.0%+427.6%0.044%Search for SEC Filing on Google Icon
4/25/2024New York State Teachers Retirement System1,915$27K0.0%N/A0.006%Search for SEC Filing on Google Icon
4/18/2024Allspring Global Investments Holdings LLC14,763$0.21M0.0%+427.6%0.044%Search for SEC Filing on Google Icon
3/5/2024Wellington Management Group LLP1,047,780$15.81M0.0%+0.2%3.140%Search for SEC Filing on Google Icon
2/14/202472 Investment Holdings LLC172,600$2.61M11.6%-66.1%0.517%Search for SEC Filing on Google Icon
2/13/2024Tower Research Capital LLC TRC5,780$87K0.0%+476.3%0.017%Search for SEC Filing on Google Icon
2/6/2024Swiss National Bank23,000$0.35M0.0%-8.7%0.069%Search for SEC Filing on Google Icon
1/30/2024Strs Ohio24,100$0.36M0.0%+792.6%0.072%Search for SEC Filing on Google Icon
1/12/2024SG Americas Securities LLC11,714$0.18M0.0%+27.7%0.035%Search for SEC Filing on Google Icon
12/1/2023Wellington Management Group LLP1,045,652$16.52M0.0%+2.6%3.134%Search for SEC Filing on Google Icon
11/15/2023Redmile Group LLC1,284,000$20.29M1.0%-2.1%3.848%Search for SEC Filing on Google Icon
11/14/2023Corton Capital Inc.10,485$0.17M0.1%-42.0%0.031%Search for SEC Filing on Google Icon
10/27/2023Allspring Global Investments Holdings LLC2,798$44K0.0%N/A0.008%Search for SEC Filing on Google Icon
10/27/2023TD Asset Management Inc119,254$1.88M0.0%+100.0%0.359%Search for SEC Filing on Google Icon
10/13/2023SG Americas Securities LLC9,174$0.15M0.0%N/A0.028%Search for SEC Filing on Google Icon
9/21/2023Barclays PLC6,440$97K0.0%-37.0%0.019%Search for SEC Filing on Google Icon
8/11/2023Nan Fung Group Holdings Ltd49,082$0.74M0.5%-33.3%0.148%Search for SEC Filing on Google Icon
8/4/2023American International Group Inc.10,299$0.16M0.0%N/A0.031%Search for SEC Filing on Google Icon
7/31/2023Strs Ohio2,700$40K0.0%N/A0.008%Search for SEC Filing on Google Icon
5/11/2023CHI Advisors LLC56,374$0.82M0.2%N/A0.170%Search for SEC Filing on Google Icon
5/9/2023Y Intercept Hong Kong Ltd10,188$0.15M0.0%N/A0.031%Search for SEC Filing on Google Icon
2/14/2023683 Capital Management LLC10,355$0.14M0.0%N/A0.033%Search for SEC Filing on Google Icon
2/9/2023Citigroup Inc.51,042$0.69M0.0%+3,124.4%0.163%Search for SEC Filing on Google Icon
2/8/2023Swiss National Bank26,500$0.36M0.0%N/A0.084%Search for SEC Filing on Google Icon
11/15/2022TCG Crossover Management LLC642,189$10.12M3.0%-3.2%2.045%Search for SEC Filing on Google Icon
11/15/2022Laurion Capital Management LP199,066$3.14M0.0%+54.2%0.634%Search for SEC Filing on Google Icon
11/10/2022Nan Fung Group Holdings Ltd141,593$2.23M1.4%-18.4%0.451%Search for SEC Filing on Google Icon
11/7/2022TD Asset Management Inc.59,496$0.93M0.0%+3.2%0.189%Search for SEC Filing on Google Icon
8/15/2022Laurion Capital Management LP129,066$1.57M0.0%N/A0.411%Search for SEC Filing on Google Icon
5/27/2022Walleye Capital LLC44,652$0.42M0.0%N/A0.142%Search for SEC Filing on Google Icon
5/5/2022New York State Common Retirement Fund4,880$46K0.0%N/A0.016%Search for SEC Filing on Google Icon
2/18/2022TCG Crossover Management LLC663,694$11.36M5.3%N/A2.126%Search for SEC Filing on Google Icon
2/14/2022Redmile Group LLC1,954,420$33.46M0.8%N/A6.262%Search for SEC Filing on Google Icon
2/14/202272 Investment Holdings LLC509,024$8.71M7.7%N/A1.631%Search for SEC Filing on Google Icon
2/14/2022Suvretta Capital Management LLC106,000$1.82M0.0%N/A0.340%Search for SEC Filing on Google Icon
2/14/2022Ghisallo Capital Management LLC15,000$0.26M0.0%N/A0.048%Search for SEC Filing on Google Icon
2/14/2022Goldman Sachs Group Inc.7,626,182$130.56M0.0%N/A24.433%Search for SEC Filing on Google Icon
2/11/2022MPM Asset Management LLC4,425,784$75.77M16.4%N/A14.179%Search for SEC Filing on Google Icon
2/10/2022TD Asset Management Inc.57,675$0.99M0.0%N/A0.185%Search for SEC Filing on Google Icon
2/8/2022Northern Trust Corp79,483$1.36M0.0%N/A0.255%Search for SEC Filing on Google Icon
2/3/20225AM Venture Management LLC4,408,379$75.47M14.2%N/A14.124%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Entrada Therapeutics logo
Entrada Therapeutics, Inc., a clinical-stage biotechnology company, develops endosomal escape vehicle (EEV) therapeutics for the treatment of multiple neuromuscular diseases. Its EEV platform develops a portfolio of oligonucleotide, antibody, and enzyme-based programs. Its therapeutic candidates, which include ENTR-601-44, which is in Phase I clinical trial for the treatment of Duchenne muscular dystrophy; and ENTR-701, which is in Phase 1/2 clinical trial for the treatment of myotonic dystrophy type 1. The company also offers ENTR-601-45 and ENTR-601-50, which are in preclinical trail for the treatment of Duchenne muscular dystrophy; and ENTR-501, an intracellular thymidine phosphorylase enzyme replacement therapy, which is in preclinical trail for the treatment of mitochondrial neurogastrointestinal encephalomyopathy. Entrada Therapeutics, Inc. has a strategic collaboration and license agreement with Vertex Pharmaceuticals Incorporated to research, develop, manufacture, and commercialize ENTR-701. The company was formerly known as CycloPorters, Inc. and changed its name to Entrada Therapeutics, Inc. in October 2017. Entrada Therapeutics, Inc. was incorporated in 2016 and is headquartered in Boston, Massachusetts.
Read More on Entrada Therapeutics

Today's Range

Now: $17.59
Low: $16.86
High: $18.00

50 Day Range

MA: $18.54
Low: $16.84
High: $21.59

52 Week Range

Now: $17.59
Low: $11.35
High: $21.79

Volume

357,928 shs

Average Volume

108,883 shs

Market Capitalization

$658.22 million

P/E Ratio

11.06

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Entrada Therapeutics?

Entrada Therapeutics' top insider shareholders include:
  1. Bioventures 2018 LP Mpm (Major Shareholder)
  2. Dipal Doshi (CEO)
  3. Natarajan Sethuraman (Insider)
  4. Nathan J Dowden (COO)
  5. Kory James Wentworth (CFO)
  6. Peter S Kim (Director)
  7. Nerissa Kreher (Insider)
Learn More about top insider investors at Entrada Therapeutics.

Who are the major institutional investors of Entrada Therapeutics?

Entrada Therapeutics' top institutional shareholders include:
  1. FMR LLC — 4.66%
  2. Janus Henderson Group PLC — 4.57%
  3. Wellington Management Group LLP — 2.75%
  4. Geode Capital Management LLC — 1.54%
  5. State Street Corp — 1.25%
  6. Jacobs Levy Equity Management Inc. — 0.54%
Learn More about top institutional investors of Entrada Therapeutics stock.

Which institutional investors are selling Entrada Therapeutics stock?

Within the last quarter, TRDA stock was sold by these institutional investors:
  1. FMR LLC
  2. Jane Street Group LLC
  3. Allspring Global Investments Holdings LLC
  4. Wellington Management Group LLP
Within the last year, company insiders that have sold Entrada Therapeutics company stock include:
  1. Bioventures 2018 LP Mpm (Major Shareholder)
  2. Dipal Doshi (CEO)
  3. Natarajan Sethuraman (Insider)
  4. Nathan J Dowden (COO)
  5. Kory James Wentworth (CFO)
Learn More investors selling Entrada Therapeutics stock.

Which institutional investors are buying Entrada Therapeutics stock?

In the previous quarter, TRDA stock was bought by institutional investors including:
  1. Janus Henderson Group PLC
  2. Connor Clark & Lunn Investment Management Ltd.
  3. Massachusetts Financial Services Co. MA
  4. Jacobs Levy Equity Management Inc.
  5. Geode Capital Management LLC
  6. XTX Topco Ltd
  7. Los Angeles Capital Management LLC
  8. Barclays PLC